Homepage >>>
by Andrew Berens, MD, Senior Healthcare Analyst and Grace Guo, Bloomberg Industries Avanir’s Nuedexta may receive a decision from the Committee for Medicinal Products for Human Use (CHMP) this week as a treatment for pseudobulbar affect (PBA). Approval in the EU would be the second regulatory nod for the drug. PBA is also called emotional [...]
JPMorgan Chase & Co. and Wells Fargo & Co.’s earnings were dragged down $1.1 billion on hedges of mortgage servicing rights in the first quarter, as a rise in Treasury yields coupled with a surge in U.S. home prices prompted the banks to revise their prepayment models. Click here to continue reading.
While the U.S. has delayed final Basel III implementation, most of the largest publicly traded banks are in early compliance based on their pro-forma estimates. Click here to continue reading.
Page 1 of Structured Notes this week: Gold’s decline of about 14 percent in two days put more than a billion dollars of U.S. structured notes at risk. Inside the full edition: Rabobank makes deep cuts in its equity derivatives team amid tighter regulations, sales of notes in the Brazilian real tied to government debt [...]
by Sam Fazeli, Director Bloomberg Industries, Europe The diabetes market is rapidly growing in China, leading to a significant opportunity for companies with complete diabetes portfolios like Novo Nordisk and Sanofi. In addition to urbanization and obesity rates, diabetes prevalence has been fueled by the region’s aging population. The prevalence of the disease increased at [...]
Our front page this week: Low volatility of the S&P 500 is depressing issuance of notes linked to the benchmark. Inside: Sales of notes that mirror the bets made by the “London Whale” are increasing; uridashi note issuance in Japan is climbing because of early redemptions caused by rising stocks; Thomas Layton of Raymond James [...]
Banks face further scrutiny from global regulators into their risk models amid concerns lenders are underestimating the amount of capital they need to cope with losses. Click here to continue reading.
The introduction of new FDIC regulations has slowed the tightening of spreads on Triple A rated tranches of U.S. CLOs backed by widely syndicated loans. Once investors digest the changes and recent supply is absorbed, the market may tighten to its lowest since 2008. CLICK HERE FOR MORE
The Bank of Japan’s strategy to end almost two decades of stagnation through unprecedented monetary stimulus may set off a ticking time-bomb for financial markets if it’s not followed by extensive structural reforms. Such reforms, critical to the success of Prime Minister Shinzo Abe’s economic program — dubbed Abenomics — have historically proved difficult to implement. The combination of a [...]



